Market Place
Sourcing Support
Enforcement Report - Week of April 15, 2026
15 Apr 2026 //
FDA
Enforcement Report - Week of April 1, 2026
01 Apr 2026 //
FDA
Enforcement Report - Week of December 10, 2025
10 Dec 2025 //
FDA
Enforcement Report - Week of November 12, 2025
12 Nov 2025 //
FDA
Enforcement Report - Week of November 5, 2025
05 Nov 2025 //
FDA
Health Canada Issues Recalls of Teva`s Seasonique tablet
06 Jun 2025 //
HEALTH CANADA
Health Canada Issues Recalls of Teva`s Seasonale Tablet
06 Jun 2025 //
HEALTH CANADA
Health Canada Issues Recalls of Teva`s Teva 5-ASA
07 Apr 2025 //
HEALTH CANADA
Enforcement Report - Week of February 12, 2025
12 Feb 2025 //
FDA
Enforcement Report - Week of July 24, 2024
24 Jul 2024 //
FDA
Enforcement Report - Week of June 26, 2024
26 Jun 2024 //
FDA
Enforcement Report - Week of April 17, 2024
17 Apr 2024 //
FDA
Enforcement Report - Week of April 3, 2024
03 Apr 2024 //
FDA
Enforcement Report - Week of February 21, 2024
21 Feb 2024 //
FDA
Enforcement Report - Week of February 7, 2024
07 Feb 2024 //
FDA
Enforcement Report - Week of December 6, 2023
06 Dec 2023 //
FDA
Enforcement Report - Week of May 31, 2023
31 May 2023 //
FDA
Enforcement Report - Week of April 12, 2023
12 Apr 2023 //
FDA
Enforcement Report - Week of March 22, 2023
22 Mar 2023 //
FDA
Enforcement Report - Week of March 15, 2023
15 Mar 2023 //
FDA
Health Canada Issues Recall of Teva-Atenolol 50mg due incorrect product image on the label
21 Nov 2022 //
HEALTH CANADA
Enforcement Report - Week of September 21, 2022
21 Sep 2022 //
FDA
Enforcement Report - Week of August 10, 2022
10 Aug 2022 //
FDA
Enforcement Report - Week of August 3, 2022
03 Aug 2022 //
FDA
Enforcement Report - Week of June 29, 2022
29 Jun 2022 //
FDA
Enforcement Report - Week of June 15, 2022
14 Jun 2022 //
FDA
Enforcement Report - Week of June 8, 2022
08 Jun 2022 //
FDA
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules
24 May 2022 //
FDA
Enforcement Report - Week of May 4, 2022
04 May 2022 //
FDA
Enforcement Report - Week of April 20, 2022
20 Apr 2022 //
FDA
Enforcement Report - Week of February 9, 2022
09 Feb 2022 //
FDA
Enforcement Report - Week of January 26, 2022
26 Jan 2022 //
FDA
Enforcement Report - Week of January 19, 2022
19 Jan 2022 //
FDA
Enforcement Report - Week of December 29, 2021
29 Dec 2021 //
FDA
Enforcement Report - Week of November 24, 2021
24 Nov 2021 //
FDA
Enforcement Report- Week of October 27, 2021
27 Oct 2021 //
FDA
Health Canada Issues Recall of Teva`s Novo-Gesic Forte 500mg
06 Oct 2021 //
HEALTH CANADA
Enforcement Report - Week of September 8, 2021
08 Sep 2021 //
FDA
Enforcement Report - Week of August 25, 2021
25 Aug 2021 //
FDA
Health Canada Issues Recall of Multiple lots of Irbesartan, losartan & valsartan drugs
15 Jun 2021 //
HEALTH CANADA
Health Canada Issues Recall of Teva Canada`s Losartan
25 May 2021 //
HEALTH CANADA
Enforcement Report - Week of March 24, 2021
24 Mar 2021 //
FDA
Enforcement Report - Week of March 10, 2021
10 Mar 2021 //
FDA
Enforcement Report - Week of March 3, 2021
03 Mar 2021 //
FDA
Enforcement Report - Week of November 18, 2020
18 Nov 2020 //
FDA
Enforcement Report for Week of October 7, 2020
07 Oct 2020 //
FDA
Health Canada Issues Recall of Teva Canada`s-Cephalexin
21 Aug 2020 //
HEALTH CANADA
Enforcement Report - Week of August 19, 2020
19 Aug 2020 //
FDA
Enforcement Report - Week of July 1, 2020
01 Jul 2020 //
FDA
Enforcement Report - Week of June 10, 2020
10 Jun 2020 //
FDA
Enforcement Report - Week of May 13, 2020
13 May 2020 //
FDA
Enforcement Report - Week of March 11, 2020
12 Mar 2020 //
FDA
Enforcement Report - Week of February 26, 2020
26 Feb 2020 //
FDA
Enforcement Report - Week of February 19, 2020
20 Feb 2020 //
FDA
Enforcement Report - Week of February 12, 2020
12 Feb 2020 //
FDA
Health Canada Issues Recall of Teva Canada Ranitidine Product
17 Oct 2019 //
HEALTH CANADA
